A5016971873- Dermatology and Skin Diseases
- Allergic Rhinitis and Sensitization
- Asthma and respiratory diseases
- Contact Dermatitis and Allergies
- Dementia and Cognitive Impairment Research
- Food Allergy and Anaphylaxis Research
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Systems, Economic Evaluations, Quality of Life
- Inhalation and Respiratory Drug Delivery
- Alzheimer's disease research and treatments
- Health and Wellbeing Research
- Geriatric Care and Nursing Homes
- Health disparities and outcomes
- Economic and Environmental Valuation
- Environmental Impact and Sustainability
- Stoma care and complications
- Nail Diseases and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Eating Disorders and Behaviors
- Intergenerational Family Dynamics and Caregiving
- Neurological Disease Mechanisms and Treatments
- Healthcare Systems and Public Health
- Chronic Disease Management Strategies
- Pharmaceutical studies and practices
- Neurological Disorders and Treatments
Novo Nordisk (Denmark)
2024-2025
Leo Pharma (Denmark)
2017-2025
Leo Pharma (Australia)
2020
Adelphi Group (United Kingdom)
2019
ALK-Abelló (Denmark)
2014-2017
Understanding the relationship among changes in Clinical Dementia Rating (CDR), patient outcomes, and probability of progression is crucial for evaluating long-term benefits disease-modifying treatments. We examined associations Alzheimer's disease (AD) stages outcomes that are important to patients their care partners including activities daily living (ADLs), geriatric depression, neuropsychiatric features, cognitive impairment, probabilities being transitioned a facility (i.e.,...
Alzheimer's disease (AD) is considered a continuum, progressing from preclinical to mild cognitive impairment (MCI) as an early stage, before reaching clinically apparent dementia. Although it difficult assess the potential impairments in performance of patients with MCI due AD, this condition should be diagnosed possible so that, by means interventions, can maintain their quality life longer. Healthcare systems support primary care physicians effort identify AD and refer memory clinics...
An educational symposium on the importance of meaningful treatment outcomes in Alzheimer disease (AD) was sponsored by Novo Nordisk and presented at ISPOR Europe 2023. To gather insights from different stakeholders, 5 speakers pharmaceutical life sciences industry (Novo IQVIA), academia (Karolinska Institutet, Sweden), Norwegian Medical Products Agency (NOMA), as well a person living with AD, participated this titled "Time delay: Searching for Meaningful Outcome Disease Modification...
Background Social media data provide a valuable opportunity to explore the effects that Alzheimer disease (AD) has on care partners, including aspects of providing have greatest impacts their lives and well-being priorities for loved ones’ treatment. Objective The objective this social review was gain insight into impact caring someone with AD, focusing particularly psychological emotional well-being, functioning, daily life ability work, health-related quality life, relationships. Methods...
Atopic dermatitis (AD) is a pruritic or painful dermatologic disease characterized by xerosis and eczema lesions.The symptoms/signs of AD can significantly impact patients' health-related quality life (HRQoL).This study aimed to qualitatively explore the adult adolescent experience AD.A targeted literature review qualitative concept elicitation interviews with clinicians (n = 5), patients 28), 20) were conducted elicit signs/ symptoms HRQoL impacts experienced.Verbatim transcripts analyzed...
To develop a mapping algorithm for generating EQ-5D-5-level (EQ-5D-5L) utility scores from the Dermatology Life Quality Index (DLQI) in patients with atopic dermatitis (AD).The was developed using data 1232 four countries participating National Health and Wellness Study. Spearman's rank correlation coefficient used to evaluate conceptual overlap between DLQI EQ-5D-5L. Six models (ordinary least squares [OLS], Tobit, three different two-part models, regression mixture model) were tested...
Objectives Currently, patients with persistent moderate-to-severe house dust mite (HDM) allergic rhinitis despite use of symptom-relieving medication can be offered subcutaneously administered allergy immunotherapy (SQ SCIT; Alutard SQ) as standard care treatment in Denmark. Recently, a HDM sublingually tablet SLIT-tablet; ACARIZAX) has been developed for at-home treatment. The purpose this analysis is to compare the costs related and administration SQ SLIT-tablet SCIT. Methods Assuming...
Asthma affects an estimated 300 million people worldwide with the condition associated significant healthcare utilisation costs and a large impact on patient quality of life. The SQ® HDM SLIT-tablet (ACARIZAX®, Hørsholm, Denmark) is sublingually administered allergy immunotherapy tablet for house dust mite allergic asthma rhinitis has recently been licensed in Europe. To assess cost-effectiveness ACARIZAX plus pharmacotherapy versus placebo patients that uncontrolled by inhaled...
Allergic rhinitis is a global health problem that burdens society due to associated care costs and its impact on health. Standardized quality (SQ®) house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet sublingually administered allergy tablet for patients with persistent moderate severe HDM allergic despite use of pharmacotherapy.To assess the cost-effectiveness SQ SLIT-tablet in Germany suffering from rhinitis.A pharmacoeconomic analysis, based data collected double-blinded, phase...
What is this summary about? This a plain language of an article published in Future Neurology. In it, we look at why it important to diagnose Alzheimer's disease as early possible, and think about can be difficult reach diagnosis.
Introduction Alzheimer’s disease (AD), the most common cause of dementia, is becoming increasingly prevalent worldwide. Understanding current burden AD important in health economic evaluations new therapies. We aimed to estimate illness, and healthcare costs people living with using a large, comprehensive real-world database England. Methods A retrospective cohort study was undertaken Discover-NOW dataset, containing linked primary secondary care electronic records ˜3 million North West...